Emerging Vaccine Demand From Aging Populations Will Reshape Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
08 May 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$32.00
66.3% undervalued intrinsic discount15 Aug
US$10.79
1Y
-3.7%7D
4.5%